KR Choksey is bullish on Zydus Lifesciences has recommended buy rating on the stock with a target price of Rs 1201 in its ...

Sonos reported mixed first-quarter fiscal 2025 results, with revenue and earnings per share beating expectations despite revenue falling year over year.

Swiggy share price fell 7.4% after reporting a third-quarter loss of ₹799.08 crore. Total expenses increased significantly, ...

State Bank of India (SBI) is anticipated to report strong high-single-digit growth in net interest income (NII) for Q3 FY25, ...

Luxembourg, 06 February 2025 – Novem Group S.A. today published its figures for the third quarter of its financial year 2024/25. In the first nine months of financial year, Novem generated a total ...

Blue Bird Reports Fiscal 2025 First Quarter Results; Beats First Quarter Guidance; Reaffirms 2025 Guidance and Long-Term ...

Net sales of $521 million (+2% actual rates, +4% constant exchange rates (CER) core growth); diluted EPS of $0.39 and ...

但是，在核心投资逻辑受到自动驾驶威胁 & 当前对应 26 年 20x 以上 PE 这并不算便宜的估值下，市场对 Uber ...

Reports Q1 revenue $4.12B, consensus $4.22B. “Emerson (EMR) began the fiscal year on a strong note, exceeding first quarter expectations for ...

KR Choksey recommended accumulate rating on Divis Laboratories with a target price of Rs 6435 in its research report dated ...

Williams' key growth driver, showing resilience with price increases and strong brand strength. Read why I downgrade SHW ...

Backlog Grows by 18.9% Year-Over-Year with TTM Book-to-Bill Ratio of 1.3x Repurchased $202 Million of our Shares During Q1 Board Authorizes $1.5 Billion for Company's ...